Abstract:Aging affects all cell types in the CNS and plays an important role in CNS diseases. However, the underlying molecular mechanisms driving these age-associated changes and their contribution to diseases are only poorly understood. The white matter in the aging brain as well as in diseases, such as Multiple sclerosis is characterized by subtle abnormalities in myelin sheaths and paranodes, suggesting that oligodendrocytes, the myelin-maintaining cells of the CNS, lose the capacity to preserve a proper myelin structure and potentially function in age and certain diseases. Here, we made use of directly converted oligodendrocytes (dchiOL) from young, adult and old human donors to study age-associated changes. dchiOL from all three age groups differentiated in an comparable manner into O4 + immature oligodendrocytes, but the proportion of MBP + mature dchiOL decreased with increasing donor age. This was associated with an increased ROS production and upregulation of cellular senescence markers such as CDKN1A, CDKN2A in old dchiOL. Comparison of the transcriptomic profiles of dchiOL from adult and old donors revealed 1324 differentially regulated genes with limited overlap with transcriptomic profiles of the donors' fibroblasts or published data sets from directly converted human neurons or primary rodent oligodendroglial lineage cells. Methylome analyses of dchiOL and human white matter tissue samples demonstrate that chronological and epigenetic age correlate in CNS white matter as well as in dchiOL and resulted in the identification of an age-specific epigenetic signature. Furthermore, we observed an accelerated epigenetic aging of the myelinated, normal appearing white matter of multiple sclerosis (MS) patients compared to healthy individuals. Impaired differentiation and upregulation of cellular senescence markers could be induced in young dchiOL in vitro using supernatants from pro-inflammatory microglia. In summary, our data suggest that physiological aging as well as inflammation-induced cellular senescence contribute to oligodendroglial pathology in inflammatory demyelinating diseases such as MS.

Aging and senescent fates of oligodendrocyte precursor cells in the mouse brain

Microglia Impede Oligodendrocyte Generation in Aged Brain

Navigating oligodendrocyte precursor cell aging in brain health

Transcriptional profiles of murine oligodendrocyte precursor cells across the lifespan

Aging Alters Olfactory Bulb Network Oscillations and Connectivity: Relevance for Aging-Related Neurodegeneration Studies

Age-associated transcriptomic and epigenetic alterations in mouse hippocampus

Aging compromises oligodendrocyte precursor cell maturation and efficient remyelination in the monkey brain

Replenishing the Aged Brains: Targeting Oligodendrocytes and Myelination?

Myelin Degeneration and Diminished Myelin Renewal Contribute to Age-Related Deficits in Memory.

Age-related decline in oligodendrogenesis retards white matter repair in mice

Impaired oligodendrogenesis in the white matter of aged mice following diffuse traumatic brain injury

Spatial transcriptomic analysis reveals inflammatory foci defined by senescent cells in the white matter, hippocampi and cortical grey matter in the aged mouse brain

Oligodendrocyte Progenitor Cells Become Regionally Diverse and Heterogeneous with Age

Amyloidosis is associated with thicker myelin and increased oligodendrogenesis in the adult mouse brain

Atlas of the aging mouse brain reveals white matter as vulnerable foci

Increased Axonal Bouton Dynamics in the Aging Mouse Cortex

Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS

Compartmentalized ciliation changes of oligodendrocytes in aged mouse optic nerve

Proteomic Signature and Mrna Expression in Hippocampus of SAMP8 and SAMR1 Mice During Aging

Multi-omics analysis reveals neuroinflammation, activated glial signaling, and dysregulated synaptic signaling and metabolism in the hippocampus of aged mice

Biosystems Study of the Molecular Networks Underlying Hippocampal Aging Progression and Anti-aging Treatment in Mice.